Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Creatine Kinase Assay Kit

AcA Plasma, Serum
Catalog No. ABIN1000303
  • Target
    Creatine Kinase
    Application
    Activity Assay (AcA)
    Sample Type
    Plasma, Serum
    Specificity
    5 U/L
    Characteristics
    Sensitive and accurate. Detection range: 5 to 300 U/L creatine kinase in 96-well plate assay.
    Convenient. The procedure involves adding a single working reagent, and reading the optical density at 20 min and 40 min at room temperature or 37°C.
    High-throughput. Can be readily automated as a high-throughput 96- well plate assay for thousands of samples per day.
    Components
    Assay Buffer: 12 mL. Substrate Solution: 1.0 mL. Enzyme Mix: 120 µL. Calibrator: 150 µL.
    Material not included
    Pipeting (multi-channel) devices. Clear-bottom 96-well plates (e.g. Corning Costar) and plate reader.
  • Application Notes
    Direct Assays: CK in serum, plasma and other biological samples.
    Pharmacology: effects of drugs on CK activity.
    Comment

    This assay is based on an enzyme-catalyzed kinetic reaction. Addition of Reconstituted Reagent should be quick and mixing should be brief but thorough. Use of multi-channel pipettor is recommended.

    Protocol
    1. Calibrator: transfer 110 µL water and (10 µL Calibrator + 100 µL water) into separate wells of a clear bottom 96-well plate. Samples: transfer 10 µL samples into separate wells. Add 100 µL Reconstituted Reagent and tap plate to mix.
    2. Reaction. Incubate at room temperature or 37°C. CK is fully activated within 20 min by glutathione provided in the Substrate Solution. Read OD340nm at 20 min and again at 40 min.
    Sample Preparation

    Use non-hemolyzed samples. Samples should be assayed within 4 hours of blood collection if they remain at room temperature, or within 12 hours if stored at 4°C. Samples can be stored at -80°C and should be thawed only once. If turbidity is observed, centrifuge sample and use clear supernatant for assay. Reagent Reconstitution. Bring all components to room temperature. For each reaction well, mix 10 µL Substrate Solution, 100 µL Assay Buffer and 1 µL Enzyme Mix. Fresh reconstitution is recommended. If the assay is to be carried out at 37°C, warm up the Reconstituted Reagent at 37°C.

    Restrictions
    For Research Use only
  • Storage
    -20 °C
  • Lu, Moore, Liu, Schaefer: "Phosphorylation of ARC is a critical element in the antiapoptotic effect of anesthetic preconditioning." in: Anesthesia and analgesia, Vol. 112, Issue 3, pp. 525-31, (2011) (PubMed).

    Li, Guan, Chen, Gleave, Nguan, Du: "Reduction of cold ischemia-reperfusion injury by graft-expressing clusterin in heart transplantation." in: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, Vol. 30, Issue 7, pp. 819-26, (2011) (PubMed).

    Ren, Song, Lu, Chen: "Cardioprotection by ischemic postconditioning is lost in isolated perfused heart from diabetic rats: Involvement of transient receptor potential vanilloid 1, calcitonin gene-related peptide and substance P." in: Regulatory peptides, Vol. 169, Issue 1-3, pp. 49-57, (2011) (PubMed).

    Uchida, Itaka, Chen, Osada, Miyata, Ishii, Harada-Shiba, Kataoka: "Combination of chondroitin sulfate and polyplex micelles from Poly(ethylene glycol)-poly{N'-[N-(2-aminoethyl)-2-aminoethyl]aspartamide} block copolymer for prolonged in vivo gene transfection with reduced toxicity." in: Journal of controlled release : official journal of the Controlled Release Society, Vol. 155, Issue 2, pp. 296-302, (2011) (PubMed).

    Kwon, Kim, Rhee, Park, Kim, Kim, Lee, Kwon: "ASB9 interacts with ubiquitous mitochondrial creatine kinase and inhibits mitochondrial function." in: BMC biology, Vol. 8, pp. 23, (2010) (PubMed).

    Itaka, Osada, Morii, Kim, Yun, Kataoka: "Polyplex nanomicelle promotes hydrodynamic gene introduction to skeletal muscle." in: Journal of controlled release : official journal of the Controlled Release Society, Vol. 143, Issue 1, pp. 112-9, (2010) (PubMed).

    Annecke, Chappell, Chen, Jacob, Welsch, Sommerhoff, Rehm, Conzen, Becker: "Sevoflurane preserves the endothelial glycocalyx against ischaemia-reperfusion injury." in: British journal of anaesthesia, Vol. 104, Issue 4, pp. 414-21, (2010) (PubMed).

    Shi, Boadu, Mercan, Le, Flach, Zhang, Tyner, Olwin, Bennett: "MAP kinase phosphatase-1 deficiency impairs skeletal muscle regeneration and exacerbates muscular dystrophy." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 24, Issue 8, pp. 2985-97, (2010) (PubMed).

    Steen, Wilczak, Hoogduin, Koch, De Keyser: "Reduced creatine kinase B activity in multiple sclerosis normal appearing white matter." in: PLoS ONE, Vol. 5, Issue 5, pp. e10811, (2010) (PubMed).

    Gawlik, Durbeej: "Transgenic overexpression of laminin alpha1 chain in laminin alpha2 chain-deficient mice rescues the disease throughout the lifespan." in: Muscle & nerve, Vol. 42, Issue 1, pp. 30-7, (2010) (PubMed).

    Pruksakorn, Lirdprapamongkol, Chokchaichamnankit, Subhasitanont, Chiablaem, Svasti, Srisomsap: "Metabolic alteration of HepG2 in scaffold-based 3-D culture: proteomic approach." in: Proteomics, Vol. 10, Issue 21, pp. 3896-904, (2010) (PubMed).

    Lu, Liu, Wang, Schaefer: "Activation of NF-kappaB is a critical element in the antiapoptotic effect of anesthetic preconditioning." in: American journal of physiology. Heart and circulatory physiology, Vol. 296, Issue 5, pp. H1296-304, (2009) (PubMed).

    Kim, Ha, Jin, Shi, Lee, Kim, Seo, Choi, Kim, Kang, Lee, Chang: "Palmatine from Coptidis rhizoma reduces ischemia-reperfusion-mediated acute myocardial injury in the rat." in: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, Vol. 47, Issue 8, pp. 2097-102, (2009) (PubMed).

    Branciari, Mugnai, Mammoli, Miraglia, Ranucci, Dal Bosco, Castellini: "Effect of genotype and rearing system on chicken behavior and muscle fiber characteristics." in: Journal of animal science, Vol. 87, Issue 12, pp. 4109-17, (2009) (PubMed).

  • Target
    Creatine Kinase
    Background
    Quantitative determination of creatine kinase activity at 340nm.
    Procedure: 5 min.

    Creatine Kinase (CK), also known as creatine phosphokinase (CPK), is an enzyme (EC 2.7.3.2) expressed predominantly in skeletal muscle, smooth muscle and the brain. The CK enzyme consists of two subunits, which can be either B (brain type) or M (muscle type), and hence three different isoenzymes: CK-MM, CK-BB and CK-MB. CK catalyzes the conversion of creatine to phosphocreatine, consuming adenosine triphosphate (ATP) and generating adenosine diphosphate (ADP) and the reverse reaction. CK is often determined routinely in emergency patients with chest pain and acute renal failure. Elevation of CK is an indication of damage to muscle and has been associated with injury, rhabdomyolysis, myocardial infarction, myositis, myocarditis, malignant hyperthermia and neuroleptic malignant syndrome, etc. Lower levels can be an indication of alcoholic liver disease and rheumatoid arthritis. Simple, direct and automation-ready procedures for measuring CK activity are very desirable. This Creatine Kinase Assay Kit is based on enzyme coupled reactions in which creatine phosphate and ADP is converted to creatine and ATP by CK, the generated ATP is used to phosphorylate glucose by hexokinase to generate glucose-6-phosphate, which is then oxidized by NADP in the presence of glucose-6-phosphate dehydrogenase. The produced NADPH, measured at 340 nm, is proportionate to the CK activity in the sample.
You are here:
Support